03 maj: CF Industries 1Q Net Up 31% As Revenue Rises
03 maj: UPDATE: US Treasury To Sell, Restructure Most Bank Investments
03-05-2012 23:24:00

Shell New Zealand Takes Over Great South Basin Exploration - Report

Relateret indhold

WELLINGTON -(Dow Jones)- Royal Dutch Shell PLC's (RDSB.LN) unit Shell New Zealand has taken over control of a joint-venture exploration in the Great South Basin, saying there are good indications of natural gas after NZ$100 million (US$80 million) of exploration in the "frontier" area, Fairfax-owned news website Stuff reported Friday.

Shell has assumed operatorship of the New Zealand exploration license PEP 50119 in the Great South Basin from joint venture partner OMV New Zealand, a unit of Austria's OMV AG (OMV.VI). The basin is located off the coast of New Zealand's South Island.

Rob Jager, the chairman of the Shell companies in New Zealand, was quoted as saying a final decision on drilling an exploration well would be taken at a later stage, with a possible time frame for a test well being in the southern hemisphere summer of 2014/15.

The cost of drilling a single offshore well in New Zealand was in the order of NZ$200 million given the expense of bringing a specialised rig from somewhere like the Gulf of Mexico, the report said.

Newspaper website: http://www.stuff.co.nz

-Wellington Bureau, Dow Jones Newswires; 64-4-471-5990; djnews.wellington@dowjones.com

(END) Dow Jones Newswires

May 03, 2012 17:24 ET (21:24 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Maersk Line-chef tager på charmeoffensiv i Kina

19-09-2014 15:47:03
Den administrerende direktør for Maersk Line, Søren Skou, har besøgt de kinesiske myndigheder i et forsøg på at skaffe opbakning til en ny shipping-alliance med..

Novo/Sydbank: Novo sidder tungt på diabetes-tronen

19-09-2014 12:17:21
Sydbank fastholder sin anbefaling af Novo Nordisk-aktien til trods for, at den amerikanske lægemiddelstyrelse, FDA, torsdag aften har godkendt Novo-konkurrenten..

Novo: Nygodkendt diabetesmiddel giver lynhurtigt effekt

19-09-2014 11:31:02
Novo Nordisks nye kombinationspræparat til behandling af type 2 diabetes, Xultophy, yder allerede efter fire uger en betydelig blodsukkerkontrol.Det fremgår af ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Jyske: Svagt momentum bag lavere kursmål
2
Aktier/åbning: C20 styrer mod rekord efter skotsk afstemning
3
Novo får godkendt kombinationsmidlet Ideglira i EU
4
Aktier/tendens: Skotsk afstemning løfter stemningen
5
Aktier/middag: Skotterne sender Vestas og C20 til vejrs

Relaterede aktiekurser

Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. september 2014 05:56:14
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140919.1 - EUROWEB3 - 2014-09-20 05:56:14 - 2014-09-20 05:56:14 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x